News
UPS Healthcare Opens Logistics Facility in Dublin with EUR 12 Million Investment
UPS Healthcare has announced the opening of a first-of-its-kind healthcare logistics facility in Dublin. This EUR 12 million investment covers nearly 6,000 m² and has created 30 new jobs, demonstrating UPS's commitment to the Irish market and export growth.
The...
News
AbbVie Completes Acquisition of Landos Biopharma
AbbVie announced that it has completed its acquisition of Landos Biopharma, Inc With the completion of the acquisition, Landos is now part of AbbVie.
Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like...
News
Florida’s Efforts to Address Medication for Anxiety and Depression
Feeling overwhelmed by anxiety or depression can push you toward quick fixes like alcohol or drugs. These might offer temporary relief but can lead to dependence and bigger problems. Florida is actively working to provide better solutions for medication...
Drug Research
Novo Nordisk invests ¥4 B in China for sterile preparation expansion project
Novo Nordisk has announced that it would invest approximately 4 billion yuan (¥) in Tianjin for a sterile preparation expansion project and recently held a groundbreaking ceremony for the expansion project.
On the day of the event, leaders from the...
Drug Research
WuXi AppTec breaks ground on new R&D and manufacturing site in Singapore
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has announced the groundbreaking of its new R&D and manufacturing site in Singapore.
This milestone,...
Drug Research
AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore
AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a...
Drug Research
Germany’s Merck KGaA acquires Mirus Bio for $600 M
Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, whereby Merck KGaA, Darmstadt,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
